Windtree Therapeutics (WINT) Insider Trading & Ownership $4.35 -0.45 (-9.38%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$4.45 +0.10 (+2.30%) As of 02/21/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Windtree Therapeutics (NASDAQ:WINT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.33%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$4,914.00Number OfInsiders Selling(Last 12 Months)0 Get WINT Insider Trade Alerts Want to know when executives and insiders are buying or selling Windtree Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address WINT Insider Buying and Selling by Quarter Windtree Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/8/2024Craig FraserCEOBuy108$45.50$4,914.00 (Data available from 1/1/2013 forward) WINT Insider Trading Activity - Frequently Asked Questions Who is on Windtree Therapeutics's Insider Roster? The list of insiders at Windtree Therapeutics includes Craig Fraser, John P Hamill, and Steven Simonson. Learn more on insiders at WINT. What percentage of Windtree Therapeutics stock is owned by insiders? 0.33% of Windtree Therapeutics stock is owned by insiders. Learn more on WINT's insider holdings. Which Windtree Therapeutics insiders have been buying company stock? The following insider purchased WINT shares in the last 24 months: Craig Fraser ($8,235.00). How much insider buying is happening at Windtree Therapeutics? Insiders have purchased a total of 111 WINT shares in the last 24 months for a total of $8,235.00 bought. Windtree Therapeutics Key ExecutivesMr. Craig E. Fraser (Age 59)Chairman, President, CEO & Interim Principal Officer Compensation: $567.2k1 recent tradesMr. Eric L. Curtis M.B.A. (Age 56)Senior VP & COO Compensation: $411.3kDr. Steven G. Simonson M.D. (Age 65)M.H.S, Senior VP & Chief Medical Officer Compensation: $448kMs. Jamie McAndrew (Age 44)VP, Controller, Chief Accounting Officer & Corporate Secretary Mr. George Cox (Age 72)Vice President of Technical Operations Dr. Pratap ParuchuruExecutive Director of Clinical DevelopmentMs. Tracy RarickHead of Operations & Program Management More Insider Trading Tools from MarketBeat Related Companies SNGX Insider Buying ONVO Insider Buying ALZN Insider Buying FRTX Insider Buying SYRS Insider Buying SONN Insider Buying UPXI Insider Buying GTBP Insider Buying ADIL Insider Buying LIPO Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:WINT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Windtree Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Windtree Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
